Position in NVS
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$310,932
+$7,876 QoQ
Shares Held
1,984
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#419
of 649 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Pacifica Partners Inc. holds $7,399,924 across 11 Drug Manufacturers - General names. NVS ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,013 | $5,590,641 | |
| 2 | ABBV |
AbbVie Inc.
|
1,990 | $500,763 | |
| 3 | LLY |
ELI LILLY & Co
|
328 | $393,413 | |
| 4 | AMGN |
Amgen Inc
|
967 | $350,170 | |
| 5 | NVS |
Novartis AG
This page
|
1,984 | $310,932 | |
| 6 | MRK |
Merck & Co., Inc.
|
1,482 | $190,437 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
310 | $39,165 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
230 | $13,252 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $310,932 | 1,984 | Shares | Defined | 2026-07-13 | |
| 2026-03-31 | $303,056 | 1,984 | Shares | Defined | 2026-04-09 | |
| 2025-12-31 | $273,534 | 1,984 | Shares | Defined | 2026-01-09 | |
| 2025-09-30 | $254,428 | 1,984 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $240,083 | 1,984 | Shares | Defined | 2025-07-14 | |
| 2025-03-31 | $221,176 | 1,984 | Shares | Defined | 2025-04-08 | |
| 2024-12-31 | $237,533 | 2,441 | Shares | Defined | 2025-01-14 | |
| 2024-09-30 | $280,763 | 2,441 | Shares | Defined | 2024-10-07 | |
| 2024-06-30 | $259,868 | 2,441 | Shares | Defined | 2024-07-11 | |
| 2024-03-31 | $236,117 | 2,441 | Shares | Defined | 2024-04-12 | |
| 2023-12-31 | $246,467 | 2,441 | Shares | Defined | 2024-01-08 | |
| 2023-09-30 | $327,072 | 3,211 | Shares | Defined | 2023-10-10 | |
| 2023-06-30 | $324,022 | 3,211 | Shares | Defined | 2023-07-17 | |
| 2023-03-31 | $295,412 | 3,211 | Shares | Defined | 2023-04-11 | |
| 2022-12-31 | $291,301 | 3,211 | Shares | Defined | 2023-01-19 | |
| 2022-09-30 | $214,196 | 2,818 | Shares | Defined | 2022-10-14 | |
| 2022-06-30 | $238,205 | 2,818 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $249,999 | 2,849 | Shares | Defined | 2022-04-12 | |
| 2021-12-31 | $249,202 | 2,849 | Shares | Defined | 2022-01-13 | |
| 2021-09-30 | $232,991 | 2,849 | Shares | Defined | 2021-10-07 | |
| 2021-06-30 | $261,585 | 2,867 | Shares | Defined | 2021-07-14 | |
| 2021-03-31 | $242,421 | 2,836 | Shares | Defined | 2021-04-08 | |
| 2020-12-31 | $266,103 | 2,818 | Shares | Defined | 2021-01-13 | |
| 2020-09-30 | $245,053 | 2,818 | Shares | Defined | 2020-10-13 | |
| 2020-06-30 | $246,124 | 2,818 | Shares | Defined | 2020-07-15 | |
| 2020-03-31 | $226,242 | 2,744 | Shares | Defined | 2020-04-15 | |
| No filing history on record for this holder in this stock. | ||||||